Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Antioxidants/sodium channel blockers from Takeda

April 14, 1997

Fournier discloses bradykinin antagonists

April 14, 1997

Astra reveals novel opioid peptides

April 14, 1997

PEP inhibitors from Chinoin

April 14, 1997

Pfizer reports new salt of known NMDA antagonist

April 14, 1997

First launch for new indication of cabergoline

April 11, 1997

Synthelabo prepares serotonergic agents

April 11, 1997

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Astra prepares NOS inhibitors

April 11, 1997

Selective 5-HT1Dalpha receptor agonists from MS&D

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...